Pro-Dex, Inc.
NASDAQ:PDEXMedical - Instruments & Supplies
+$3.54 today
- Market cap
- $204.61M
- Beta
- -0.00
- P/E (TTM)
- 17.1
- EPS (TTM)
- $3.75
Volume 0.04M
Average 0.04M
PDEX Account Payables
Amounts the company owes suppliers for goods and services received.
Pro-Dex, Inc.NASDAQ: PDEX
Account Payables · Q3 FY2026 · quarter ended Mar 2026
Account payables falls 12.0% from a year ago
Account payables stood at $5.25M at the end of Q3 FY2026, down 12.0% from a year earlier and up 27.6% from the prior quarter. Over 3 fiscal years it compounded at +7.1% a year.
Context
- Account payables amounted to 7.0% of total assets at the end of Q3 FY2026, down 2.3 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps falling in the next quarterly balance sheet after a -12.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 4.61M USD
- Year-over-year change
- +2.2%
- 4-year CAGR
- +5.2%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 4.61M | +2.2% |
| FY2024 | 2024-06-30 | 4.51M | +99.6% |
| FY2023 | 2023-06-30 | 2.26M | -39.9% |
| FY2022 | 2022-06-30 | 3.76M | +0.0% |
| FY2021 | 2021-06-30 | 3.76M | — |
Account Payables vs competitors
How PDEX compares with its peers on the latest reported figures
- PDEX's Mar 2026 account payables of $5.25M is the highest of the 9 companies compared; the peer median is $2.11M.
- Its year-over-year change of -12.0% is the 8th highest of 9, against a peer median of +94.3%.
- Account payables amounts to 7.0% of total assets for PDEX, versus a peer median of 3.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $5.25M | -12.0% | +7.1% | 7.0% | |
| Mar 2026 | $4.67M | +77.2% | -8.6% | 7.5% | |
| Mar 2026 | $4.51M | +445.2% | — | 42.9% | |
| Mar 2026 | $3.85M | +111.4% | -29.7% | 10.7% | |
| Mar 2026 | $2.63M | +14.1% | +4.6% | 4.2% | |
| Mar 2026 | $1.58M | +143.5% | +2.8% | 0.9% | |
| Mar 2026 | $1.09M | +483.3% | +63.9% | 1.4% | |
| Mar 2026 | $1.08M | +29.9% | -2.8% | 3.2% | |
| Mar 2026 | $767K | -36.5% | -17.7% | 0.8% | |
| Peer median (excluding PDEX) | $2.11M | +94.3% | -2.8% | 3.7% | |
Competitors are the stored peer set for PDEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 849K | 849K | 2.94M | 2.63M | 419K |
| Short-term Investments | 755K | 755K | 1.13M | 4.22M | 6.74M |
| Net Receivables | 15.38M | 15.38M | 9.95M | 13.89M | 17.49M |
| Inventory | 12.68M | 12.68M | 16.17M | 15.27M | 22.21M |
| Other Current Assets | 710K | 710K | 494K | 262K | 24K |
| Total Current Assets | 31.17M | 31.17M | 30.98M | 36.61M | 47.3M |
| Property, Plant & Equipment (Net) | 13.42M | 13.42M | 13.2M | 12.65M | 1.05M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 118K | 118K | 81K | 54K | 26K |
| Long-term Investments | 4.08M | 4.08M | 7.52M | 1.56M | 148K |
| Tax Assets | 256K | 256K | 0 | 1.56M | 1.42M |
| Other Non-current Assets | 42K | 42K | 42K | 42K | 11.26M |
| Total Non-current Assets | 17.92M | 17.92M | 20.84M | 15.87M | 13.9M |
| Total Assets | 49.09M | 49.09M | 51.82M | 52.48M | 61.19M |
| Account Payables | 3.76M | 3.76M | 2.26M | 4.51M | 4.61M |
| Short-term Debt | 3.29M | 3.29M | 3.83M | 4.37M | 6.15M |
| Tax Payables | 544K | 544K | 453K | 632K | 186K |
| Deferred Revenue | 1.01M | 1.01M | 0 | 14K | 202K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 1.63M |
| Total Current Liabilities | 11.35M | 11.35M | 9.68M | 12.89M | 14.63M |
| Long-term Debt | 10.25M | 10.25M | 8.91M | 7.54M | 9.25M |
| Deferred Tax Liabilities | 0 | 0 | 8K | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 12.3M | 12.3M | 10.56M | 8.72M | 9.93M |
| Total Liabilities | 23.66M | 23.66M | 20.23M | 21.61M | 24.56M |
| Common Stock | 7.68M | 7.68M | 6.77M | 3.92M | 704K |
| Retained Earnings | 17.75M | 17.75M | 24.82M | 26.95M | 35.93M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 25.43M | 25.43M | 31.59M | 30.87M | 36.63M |
| Total Debt | 15.97M | 15.97M | 14.79M | 13.55M | 16.58M |
| Net Debt | 15.12M | 15.12M | 11.86M | 10.92M | 16.16M |
Pro-Dex, Inc.
NASDAQ:PDEX
Intrinsic Alpha fair value
Locked
Current Price
$63.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.